Ivan Cornella Taracido

Ivan Cornella is a scientist and entrepreneur with over two decades of experience in pharmaceutical research and drug discovery. Most recently, he co-founded Covant Therapeutics, serving as Chief Scientific Officer. Throughout his career in both entrepreneurial and intrapreneurial roles within pharma and biotech, Ivan has led teams at Roivant Sciences, Cedilla Therapeutics, Merck, AstraZeneca, Sanofi, and the Novartis Institutes for BioMedical Research. He and his teams have been pivotal in integrating chemical and molecular biology, medicinal chemistry, pharmacology, and data sciences to advance drug discovery initiatives across diverse therapeutic areas. Ivan is recognized as a subject matter expert and frequently consults for biotech firms. His professional network spans leading pharma and venture companies, startups, and academic thought leaders. He actively engages in mentoring junior scientists and in several professional science organizations. He holds a Ph.D. in Chemistry from